ABC | Volume 114, Nº3, March 2020

Original Article Candemir et al. Slow Flow and Magnetic Resonance Imaging Arq Bras Cardiol. 2020; 114(3):540-551 1. Tatli E, Yildirim T, Aktoz M. Does coronary slow flow phenomenon lead to myocardial ischemia? Int J Cardiol. 2009;131(3):e101-2. 2. Kapoor A, Goel PK, Gupta S. Slow coronary flow--a cause for angina with ST segment elevation and normal coronary arteries. A case report. Int J Cardiol.. 1998;67(3):257-61. 3. Saya S, Hennebry TA, Lozano P, Lazzara R, Schechter E. Coronary slow flow phenomenon and risk for sudden cardiac death due to ventricular arrhythmias: a case report and review of literature. Clin Cardiol. 2008;31(8):352-5. 4. Beltrame JF, Limaye SB, Horowitz JD. The coronary slow flowphenomenon- -a new coronary microvascular disorder. Cardiology. 2002;97(4):197-202. 5. Voelker W, Euchner U, Dittmann H, Karsch KR. Long-term clinical course of patients with angina and angiographically normal coronary arteries. Clin Cardiol. 1991;14(4):307-11. 6. YurtdasM, Ozcan IT, Camsar A, CicekD, Tamer L, Cin VG, et al. NT-Pro-BNP levels and their response to exercise in patients with slow coronary flow. Arq Bras Cardiol. 2012;99(6):1115-22. 7. Bruder O, Jensen C, Jochims M, FarazandehM, Barkhausen J, Schlosser T, et al. Relation of B-type natriuretic peptide (BNP) and infarct size as assessed by contrast-enhanced MRI. Int J Cardiol. 2010;144(1):53-8. 8. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100(19):1992-2002. 9. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343(20):1445-53. 10. Ambale-Venkatesh B, Lima JA. Cardiac MRI: a central prognostic tool in myocardial fibrosis. Nat Rev Cardiol. 2015;12(1):18-29. 11. Saba L, Fellini F, De FilippoM. Diagnostic value of contrast-enhanced cardiac magnetic resonance in patients with acute coronary syndrome with normal coronary arteries. Jap J Radiol. 2015;33(7):410-7. 12. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.Eur Heart J Cardiovasc Imaging. 2015;16(3):233-70. 13. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/AmericanHeart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation. 2002;106(14):1883-92. 14. Cannon CP, McCabe CH, Diver DJ, Herson S, Greene RM, Shah PK, et al. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis inMyocardial Infarction (TIMI) 4 trial. J Am Coll Cardiol. 1994;24(7):1602-10. 15. Gibson CM, Cannon CP, DaleyWL, Dodge JT, Jr., Alexander B, Jr., Marble SJ, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1996;93(5):879-88. 16. Hawkins BM, Stavrakis S, Rousan TA, Abu-Fadel M, Schechter E. Coronary slow flow--prevalence and clinical correlations. Circulation .2012;76(4):936-42. 17. Mangieri E, Macchiarelli G, Ciavolella M, Barilla F, Avella A, Martinotti A, et al. Slowcoronary flow: clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn. 1996;37(4):375-81. 18. Mosseri M, Yarom R, Gotsman MS, Hasin Y. Histologic evidence for small- vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation. 1986;74(5):964-72. 19. Cin VG, Pekdemir H, Camsar A, Cicek D, Akkus MN, Parmaksyz T, et al. Diffuse intimal thickening of coronary arteries in slow coronary flow. Jap Heart J. 2003;44(6):907-19. 20. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101(16):1899-906. 21. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR, Jr., Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000;101(9):948-54. 22. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation. 2002;106(6):653-8. 23. Delcour KS, Khaja A, ChockalingamA, Kuppuswamy S, Dresser T. Outcomes in patients with abnormal myocardial perfusion imaging and normal coronary angiogram. Angiology. 2009;60(3):318-21. 24. Bugiardini R, Manfrini O, Pizzi C, Fontana F, Morgagni G. Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation. 2004;109(21):2518-23. 25. Bugiardini R, Bairey Merz CN. Angina with “normal” coronary arteries: a changing philosophy.JAMA. 2005;293(4):477-84. 26. Sadr-Ameli MA, Saedi S, Saedi T, Madani M, Esmaeili M, Ghardoost B. Coronaryslow flow:Benignorominous?Anatol JCardiol.2015;15(7):531-5. 27. Amirzadegan A, Motamed A, Davarpasand T, Shahrzad M, Lotfi-Tokaldany M. Clinical characteristics and mid-term outcome of patients with slow coronary flow. Acta Cardiol. 2012;67(5):583-7. 28. Gokce M, Kaplan S, Tekelioglu Y, Erdogan T, Kucukosmanoglu M. Platelet function disorder in patients with coronary slow flow. Clin Cardiol. 2005;28(3):145-8. 29. YilmazH, Demir I, Uyar Z. Clinical and coronary angiographic characteristics of patients with coronary slow flow. Acta Cardiol.2008;63(5):579-84. 30. Hoey ET, Gulati GS, Ganeshan A, Watkin RW, Simpson H, Sharma S. CardiovascularMRI forassessmentof infectiousand inflammatoryconditions of the heart. AJR Am J Roent. 2011;197(1):103-12. 31. Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med. 2002;346(25):1948-53. 32. LanzaGA,BuffonA,SestitoA,NataleL,SguegliaGA,GaliutoL,etal.Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X. J Am Coll Cardiol. 2008;51(4):466-72. 33. Wohrle J, Nusser T, Merkle N, Kestler HA, Grebe OC, Marx N, et al. Myocardial perfusion reserve in cardiovascular magnetic resonance: Correlation to coronarymicrovascular dysfunction. J CardiovascMagn Res. 2006;8(6):781-7. 34. Goetze JP, Gore A, Moller CH, Steinbruchel DA, Rehfeld JF, Nielsen LB. Acute myocardial hypoxia increases BNP gene expression. FASEB J. 2004;18(15):1928-30. 35. Goetze JP, Christoffersen C, Perko M, Arendrup H, Rehfeld JF, Kastrup J, et al. Increased cardiac BNP expression associated withmyocardial ischemia. FASEB J. 2003;17(9):1105-7. 36. Bibbins-Domingo K, Ansari M, Schiller NB, Massie B, Whooley MA. B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study. Circulation. 2003;108(24):2987-92. 37. Hama N, Itoh H, Shirakami G, Nakagawa O, Suga S, Ogawa Y, et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimentalacutemyocardial infarction.Circulation.1995;92(6):1558-64. 38. Tsuruda T, Boerrigter G, Huntley BK, Noser JA, Cataliotti A, Costello- BoerrigterLC,etal.BrainnatriureticPeptide isproduced incardiacfibroblasts and induces matrix metalloproteinases. Circ Res. 2002;91(12):1127-34. References 550